BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220323T090000
DTEND;TZID=America/New_York:20220323T123000
DTSTAMP:20260407T233621
CREATED:20220209T145612Z
LAST-MODIFIED:20220209T161212Z
UID:15697-1648026000-1648038600@www.masslifesciences.com
SUMMARY:Accelerated Leadership
DESCRIPTION:The Accelerated Leadership Program provides leaders with critical leadership competencies to accelerate their performance in leading life sciences companies. Specifically\, the course will focus on leaders’ capabilities in areas of strategic planning and decision making\, influence\, collaboration\, and executive presence. The skills associated with the program\, when mastered\, can enable significant and strategic impact for a leader and their contributions to an organization. \nAgenda\nSession 1: Wednesday\, March 23rd\, 2021 09:00 AM-12:30 PM EST\nCollaborative Influence\nExploring Skills & Knowledge to Motivate employees\nStrategies to Win Support and Acceptance\nCollaborative Relationships \nSession 2: Wednesday\, March 30th\, 2021 09:00 AM-12:30 PM EST\nStrategic Planning\nDecision-Making\nAnalyzing Problems & Opportunities \nSession 3 & 4: Wednesday\, April 6th\, 2022 09:00 AM-12:30 PM EST\, Wednesday\, April 13th\, 2022 09:00 AM-12:30 PM EST\nExecutive Presence\nDeveloping Influence\, Credibility & Authenticity as Presenters and Listeners
URL:https://www.masslifesciences.com/event/accelerated-leadership/2022-03-23/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220322T235900
DTEND;TZID=America/New_York:20220322T235900
DTSTAMP:20260407T233621
CREATED:20220303T154235Z
LAST-MODIFIED:20220303T154235Z
UID:15948-1647993540-1647993540@www.masslifesciences.com
SUMMARY:Deadline to Apply for M2D2 IMPACT Cycle 3
DESCRIPTION:M2D2 has opened applications for Cycle 3 of the IMPACT program\, a 12-week accelerator program for life sciences startups innovating in the medical device space. Up to 10 startups will be selected for the cohort and will go through a series of educational workshops\, mentorship\, and more. \nThe IMPACT participants will be able to pitch their ideas to a panel of investors\, with the opportunity for a 1-on-1 meeting afterward. \nThe deadline to apply is March 22nd at 11:59pm.
URL:https://www.masslifesciences.com/event/deadline-to-apply-for-m2d2-impact-cycle-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220321T090000
DTEND;TZID=America/New_York:20220321T111500
DTSTAMP:20260407T233621
CREATED:20220201T140955Z
LAST-MODIFIED:20220209T161056Z
UID:15668-1647853200-1647861300@www.masslifesciences.com
SUMMARY:Transitioning to Leader
DESCRIPTION:Transitioning to Leader provides participants with a clear understanding of the leader-manager they aim to be and the essential skills and strategies to get them there. Approaches to effective communication and how to foster collaboration among teams (both remotely and in person) are discussed. Learn effective delegation tools to get more accomplished through direct reports. Participants will also learn the fundamentals for interviewing\, hiring\, and more. \n“Presenting ideas about communication in a different framework and using multiple examples to explain a point was the most valuable.” – Transitioning to Leader Participant\, September 2021 \nAgenda \nSession 1: Monday\, March 21st\, 2021 9:00-11:15 AM EST\nTransitioning to Leader-Manager\nSetting Employees Up for Success \nSession 2: Thursday\, March 24th\, 2021 9:00-11:15 AM EST\nLeader as Communicator\nFundamental Communication Skills and Responsibilities \nSession 3: Friday\, March 25th\, 2021 9:00-11:15 AM EST\nShaping Culture\nManager’s Role in Employee Engagement \nPlease view the discount options for courses before registering here.
URL:https://www.masslifesciences.com/event/transitioning-to-leader/2022-03-21/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220315T090000
DTEND;TZID=America/New_York:20220316T170000
DTSTAMP:20260407T233621
CREATED:20220201T150116Z
LAST-MODIFIED:20220201T150116Z
UID:15667-1647334800-1647450000@www.masslifesciences.com
SUMMARY:Intro to Biotech
DESCRIPTION:Intro to Biotech is a course that explores the business considerations in biotech as well as basic biological processes that are foundational to the biopharma and life sciences industry. The course is divided into two parts: Intro to Business and Intro to Science. Intro to Business provides an overview of regulation through instruction\, storytelling\, and small group sessions. Topics such as market share\, phases of development\, patient population\, and safety profile will be reviewed. Intro to Science focuses on the basics of cells and molecular biology that help students’ overall understanding of how a life science company operates. Lab work will also be implemented during in-person sessions. \nDate & Time \nIntro to Business – Tuesday\, March 15th\, 2022 9:00 AM -5:00 PM EST\nIntro to Science – Wednesday\, March 16th\, 2022 9:00 AM -5:00 PM EST \nPlease plan to arrive at least 15 minutes before class starts. Class will start at 9:00 AM. We will have breaks in between. \nThis course will be held in-person. Proof of vaccination or negative COVID-19 test result (72 hours prior) will be required. All participants are required to be masked except when drinking and eating. Breakfast and lunch will be provided at this all day workshop. \nPlease view the discount options for courses before registering here.
URL:https://www.masslifesciences.com/event/intro-to-biotech/
LOCATION:The Link\, 255 Main Street\, 8th Fl\, Cambridge\, MA\, United States
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220310T173000
DTEND;TZID=America/New_York:20220310T183000
DTSTAMP:20260407T233621
CREATED:20220209T154252Z
LAST-MODIFIED:20220209T154253Z
UID:15733-1646933400-1646937000@www.masslifesciences.com
SUMMARY:2022 Koch Institute Image Awards
DESCRIPTION:Celebrate the winners of the 12th annual Image Awards competition. The Koch Institute Public Galleries are proud to shine a light on the continued biomedical research happening across MIT over the past two years. Out of 135 images submitted\, ten winning images showcase a range of research into fundamental biological questions\, clinical challenges\, and human health. Featuring new technological advancements and keen scientific insights\, this evening event presents compelling stories behind award-winning research. \nJoin us on Zoom to hear livestreamed lightning talks.
URL:https://www.masslifesciences.com/event/2022-koch-institute-image-awards/
LOCATION:Zoom
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220228T110000
DTEND;TZID=America/New_York:20220228T123000
DTSTAMP:20260407T233621
CREATED:20220222T171307Z
LAST-MODIFIED:20220222T171307Z
UID:15885-1646046000-1646051400@www.masslifesciences.com
SUMMARY:2022 Bizwomen Mentoring Monday
DESCRIPTION:Join the Boston Business Journal on February 28 for this one-of-a-kind virtual event that brings together women in the business community for a morning of networking and fun in a fast-paced coaching atmosphere. \nThis event takes place in 40 Business Journal markets on the same day. This means at least 200+ women will be coached in every market or 10K women across America\, from Boston to Hawaii. \nIn Boston we’ve planned a jam-packed morning filled with meeting new people\, gaining new insights\, and making connections! The morning will be kicked off with Keynote Remarks\, 3 general panel sessions and breakout mentoring sessions. We will alternate between mentoring sessions and general sessions!
URL:https://www.masslifesciences.com/event/2022-bizwomen-mentoring-monday/
LOCATION:Online
ORGANIZER;CN="Boston Business Journal":MAILTO:boston@bizjournals.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220220T000000
DTEND;TZID=America/New_York:20220220T000000
DTSTAMP:20260407T233621
CREATED:20220209T143214Z
LAST-MODIFIED:20220209T160721Z
UID:15626-1645315200-1645315200@www.masslifesciences.com
SUMMARY:Deadline to Apply for M2D2 2022 $200K Challenge
DESCRIPTION:Entries for the 11th $200K Challenge are now open! \nSeize this once-a-year opportunity to pitch your innovation to major players in the life sciences ecosystem. Winners receive thousand$ in in-kind support to help advance their ground-breaking medical device or biotech ideas! \nEntries close February 20 at midnight ET. \nThis year\, sponsors are looking for innovative medical device solutions in multiple areas of interest\, including digital health solutions in cardiology\, automated technologies\, and SARS-CoV-2 testing technologies. Improve your chances of reaching the Finals by aligning your innovations with our sponsor’s areas of interest. \nApply here.
URL:https://www.masslifesciences.com/event/deadline-to-apply-for-m2d2-2022-200k-challenge-february-20/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220218T120000
DTEND;TZID=America/New_York:20220218T130000
DTSTAMP:20260407T233621
CREATED:20220209T145014Z
LAST-MODIFIED:20220209T145014Z
UID:15698-1645185600-1645189200@www.masslifesciences.com
SUMMARY:P&K Lunch and Learn
DESCRIPTION:P&K is a family owned and operated business providing expertly crafted custom acrylics and they are interested in working with you! Join us on Friday\, February 18th at noon on the fourth floor (M2D2) of 110 Canal Street\, Lowell\, MA. Grab some lunch and find out how P&K Custom Acrylics can help you and your business!
URL:https://www.masslifesciences.com/event/pk-lunch-and-learn/
LOCATION:M2D2\, 110 Canal Street\, Lowell\, MA\, 01852\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220217T120000
DTEND;TZID=America/New_York:20220217T130000
DTSTAMP:20260407T233621
CREATED:20220201T162503Z
LAST-MODIFIED:20220201T162503Z
UID:15591-1645099200-1645102800@www.masslifesciences.com
SUMMARY:It's Not Too Early to Think About Marketing
DESCRIPTION:Attend this BYO lunch & learn to learn about specialized marketing techniques. \nCome on an exciting journey to learn about marketing with Northeast Biomedical’s Creative Marketing Specialist\, Margaret Anne! This lunch and learn is designed to provide attendees with an understanding of the basic principles of marketing and how it relates to the medical device industry. It will include topics such as SWOT analysis\, the 7 P’s\, marketing mix options and how to market on the cheap. These marketing techniques will help you form business goals with measurable metrics. It also will help with implementing a marketing strategy across a cross functional team.
URL:https://www.masslifesciences.com/event/its-not-too-early-to-think-about-marketing/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220216T180000
DTEND;TZID=America/New_York:20220216T193000
DTSTAMP:20260407T233621
CREATED:20220209T143551Z
LAST-MODIFIED:20220209T143551Z
UID:15719-1645034400-1645039800@www.masslifesciences.com
SUMMARY:How Science Communication can Improve your Career: A Workshop on Effective Science Communication
DESCRIPTION:Speaker: Rebecca Fuoco \nIn this workshop\, Rebecca will show participants how to boost the impact of their work and elevate their careers through science communication. Topics will include press outreach and working with journalists\, social media\, and op-ed writing. \nRebecca Fuoco is the Science Communications Officer at the Green Science Policy Institute in Berkeley\, California. She leads the Institute’s efforts to get important research on harmful chemicals covered by the press and in the hands of decision-makers. Rebecca previously worked as a communications strategist for nonprofit organizations and academic research centers in the health and environmental fields. She holds a B.S. in environmental science from Cornell University and an M.P.H. degree from UC Berkeley\, where she was a Center for Health Leadership Fellow.
URL:https://www.masslifesciences.com/event/how-science-communication-can-improve-your-career-a-workshop-on-effective-science-communication/
LOCATION:Virtual Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220216T160000
DTEND;TZID=America/New_York:20220216T190000
DTSTAMP:20260407T233621
CREATED:20220201T161922Z
LAST-MODIFIED:20220201T161922Z
UID:15663-1645027200-1645038000@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-7/
LOCATION:Online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220209T120000
DTEND;TZID=America/New_York:20220209T130000
DTSTAMP:20260407T233621
CREATED:20220204T205309Z
LAST-MODIFIED:20220204T205309Z
UID:15713-1644408000-1644411600@www.masslifesciences.com
SUMMARY:Women's Health Gaps and Innovations
DESCRIPTION:Hosted by the Harvard Business School Healthcare Alumni Association\, hear from experts on women’s health innovations\, VC funding efforts to accelerate this R&D\, market and government trends impacting the development of such innovations\, and ways to incentivize more investment in this field. \nSpeakers \nLinda Greub\, CFA\, MBA 1987\, Co-Founder & Managing Partner\, Avestria Ventures\nAlicia Chong R. – Founder & CEO\, Bloomer Tech\nPadideh Kamali-Zare – Founder & CEO\, Darmiyan\nValerie Palmieri – President and CEO\, Aspira Women’s Health\nModerator\, Liz Powell\, Esq.\, MPH 2003 – Founder\, G2G Consulting
URL:https://www.masslifesciences.com/event/womens-health-gaps-and-innovations/
LOCATION:Online\, online
ORGANIZER;CN="Harvard Business School Healthcare Alumni Association":MAILTO:susan.calcio@hbshealthalumni.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220208T090000
DTEND;TZID=America/New_York:20220208T120000
DTSTAMP:20260407T233621
CREATED:20220201T152031Z
LAST-MODIFIED:20220209T160346Z
UID:15666-1644310800-1644321600@www.masslifesciences.com
SUMMARY:Building & Managing a High Performing Team
DESCRIPTION:Building & Managing a High Performing Team is intended to help leaders at all levels in the biotech and biopharma industries improve how well they participate in and lead teams. The course focuses on principles that enhance leaders’ collaboration skills and help them to better model effective collaboration for others. Participants will consider how to address some of the typical dysfunctions and challenges that can diminish a team’s effectiveness. \nAgenda \nSession 1: Tuesday\, February 8th\, 2022 9:00 AM-12:00 PM EST\nCollaboration Principle: Constructive Conflict is Essential\nCollaboration Principle: Psychological Safety Matters\nCollaboration Principle: Seek Win-Win\nCollaboration Principle: Balance Advocacy & Inquiry\nLeader as Collaborator \nSession 2: Tuesday\, February 15th\, 2022 9:00 AM-12:00 PM EST\nHigh Performing Teams – Success Factors\nBuilding a New Team\nStages of Team Development\nLeader as Lynchpin\nStakeholder Management \nSession 3: Tuesday\, February 22nd\, 2022 9:00 AM-12:00 PM EST\nThe 5 Dysfunctions of a Team\nDisagree & Commit\nFostering a One-Team Culture\nLeader as Teambuilder \nSession 4: Tuesday\, March 1st\, 2022 9:00 AM-12:00 PM EST\nMaximizing Team Performance\nMeeting Effectiveness\nFramework for Continuous Team Improvement \nPlease view the discount options for courses before registering here.
URL:https://www.masslifesciences.com/event/building-managing-a-high-performing-team/2022-02-08/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220121T100000
DTEND;TZID=America/New_York:20220121T110000
DTSTAMP:20260407T233621
CREATED:20211228T135716Z
LAST-MODIFIED:20211228T135716Z
UID:15401-1642759200-1642762800@www.masslifesciences.com
SUMMARY:Novel Design Strategies for Effective Next-Generation Nuclear Localization Signal (NLS)-Therapeutics
DESCRIPTION:In this technical session\, Creative Biolabs has invited Dr. Leyton to describe the need to develop a more precise method in investigating nuclear transport dynamics of NLS-therapeutics. Moreover\, Dr. Leyton will also present a de novo approach for generating novel NLSs with an atypical zero net-charge and evaluating various strategies to determine the worth for integration into NLS-therapeutics development. \nDuring this webinar\, we will discuss the following key points: \n• Why nuclear targeting improves drug efficacy\n• How nuclear transport functions\n• What are the significant challenges for pharmaceuticals targeting the nucleus
URL:https://www.masslifesciences.com/event/novel-design-strategies-for-effective-next-generation-nuclear-localization-signal-nls-therapeutics/
LOCATION:Online\, online
ORGANIZER;CN="Creative Biolabs":MAILTO:marketing@creative-biolabs.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220119T160000
DTEND;TZID=America/New_York:20220119T160000
DTSTAMP:20260407T233621
CREATED:20220103T201619Z
LAST-MODIFIED:20220103T201619Z
UID:15437-1642608000-1642608000@www.masslifesciences.com
SUMMARY:SeXX and Immunity: Exploring the impact of female biology on immune responses to infectious disease
DESCRIPTION:It’s Time to Address a Knowledge Gap\nThe X chromosome does more than determine sex! When we treat biological sex (XX versus XY chromosomes) as a variable in immunity and diseases\, it can lead to a new understanding of the underpinnings of disease. The COVID-19 pandemic helped amplify awareness about sex-specific differences in immunity against infection\, however\, we still have a lot to learn. Sex differences in disease outcomes are not limited to infectious diseases – they are observed in outcomes of autoimmune diseases and cancers\, and even in response to vaccination. \n\n\n\n\n\n\n\n\n\n\nMIT’s “SeXX and Immunity” Series Addresses Gap\nOn January 19\, 2022\, MIT will kick off a new series of discussions and seminars called “SeXX and Immunity.” These sessions will explore our understanding of sex differences and sex dimorphism in relation to immune responses and how presentations of infectious diseases differ based on biology. \nOur first session will feature Dr. Sabra Klein of Johns Hopkins University\, for a talk titled “SeXX matters for viral infection and vaccination.” \n\n\n\n\n\nSeminar at 4:00PM\, 32-144 \nPoster Session Reception at 5:00PM\, R&D Commons \nRegistration Information\n\n\n\n\n\n\n\n\n\n\nPre-registration deadline: January 18\, 2022 at 12:00PM\nAfter this time\, onsite registration may be available on a space-permitting basis. \nRegistration Fees (in USD) \n— Industry: $25 \n— Academic: $10 \n— Students: Complimentary (must register with academic email address and present a valid student ID.) \n— Poster Submitters: Complimentary with submitted poster (must attend in person. Poster submitters will receive information separately about abstract submission.) \n— Virtual Attendance: Complimentary (poster session not included.) \nNOTE: No refunds can be issued for changes from in-person to virtual attendance. \nPayment methods accepted: Card Card (MasterCard\, Visa\, AMEX\, Discover) or MIT account number. Registration fees are not refundable.
URL:https://www.masslifesciences.com/event/sexx-and-immunity-exploring-the-impact-of-female-biology-on-immune-responses-to-infectious-disease/
LOCATION:Stata Center\, Building 32\, 32 Vassar Street\, Cambridge\, MA\, 02139\, United States
ORGANIZER;CN="MIT":MAILTO:lindsayk@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220118
DTEND;VALUE=DATE:20220128
DTSTAMP:20260407T233621
CREATED:20211004T125406Z
LAST-MODIFIED:20211004T125406Z
UID:14666-1642464000-1643327999@www.masslifesciences.com
SUMMARY:Designing and Implementing AI Solutions for Health Care
DESCRIPTION:Applications of artificial intelligence in health care are expanding rapidly. Despite its great long-term potential\, risks and challenges remain for both AI developers and their partners in health care\, the life sciences industry and digital health. \nThis Harvard Medical School Executive Education program will allow leaders across the ecosystem to gain insights into what it takes to successfully utilize AI in the unique cultural\, economic and regulatory context of health care. Interactive sessions will address technical concepts as well as real-world implementation\, with examples drawn from health care delivery/operations and drug development. \nThe curriculum will feature a combination of live virtual class sessions\, small group application exercises\, pre-work and vigorous discussions. Upon completion of the program\, participants will be able to immediately apply insights gained to the fast-moving and complex health care sector. A certificate of completion will be provided.
URL:https://www.masslifesciences.com/event/designing-and-implementing-ai-solutions-for-health-care-3/
LOCATION:Live Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220111T120000
DTEND;TZID=America/New_York:20220111T130000
DTSTAMP:20260407T233621
CREATED:20211227T135510Z
LAST-MODIFIED:20220107T220155Z
UID:15344-1641902400-1641906000@www.masslifesciences.com
SUMMARY:MLSC 2021 Tax Incentive Program Info Session
DESCRIPTION:MLSC Tax Incentive program supports companies engaged in life sciences research and development\, commercialization and manufacturing in MA. \nThe Massachusetts Life Sciences Center (MLSC) will be launching the next round of the Tax Incentive program supporting companies engaged in life sciences research and development\, commercialization and manufacturing in Massachusetts. The program provides incentives to companies\, of all sizes\, looking to expand their efforts by creating new\, long-term jobs in Massachusetts. \nThe MLSC will be holding an informational session for companies wanting to learn more about the eligibility requirements of the Tax Incentive program. Join us on Jan. 11 at 12 p.m. \nThe MLSC will be accepting applications for the Tax Incentive program from Dec. 6\, 2021 – Feb. 4\, 2022. Learn more about the program. \nA special thank you to our partners at the Massachusetts Biomedical Initiatives for hosting.
URL:https://www.masslifesciences.com/event/mlsc-2021-tax-incentive-program-info-session/
LOCATION:Live Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211217T160000
DTEND;TZID=America/New_York:20211217T180000
DTSTAMP:20260407T233621
CREATED:20211022T182057Z
LAST-MODIFIED:20211022T182057Z
UID:14818-1639756800-1639764000@www.masslifesciences.com
SUMMARY:M2D2 IMPACT Accelerator Pitch-Off
DESCRIPTION:Hear ten medical device startups selected for the IMPACT Accelerator Program pitch their innovation to a panel of investors.\nCalling all Investors\, Medical Device Innovators\, Biotech Entrepreneurs\, and Life Sciences Industry Professionals:\nJoin the worldwide life sciences community as the startups from the Cycle 1 Cohort pitch their medical device solution to a panel of judges. These startups have been working with M2D2\, Asahi Intecc\, and Boston Scientific to advance the commercialization of their innovation through the IMPACT Accelerator Program. \nWhat is IMPACT?\nThe M2D2 IMPACT program is a12-week accelerator program that will run for 6 cycles. The program aims to advance early-stage companies looking to reshape the future of healthcare. Selected companies will have the opportunity to engage with our sponsors’ specialized research calls to help advance their business.
URL:https://www.masslifesciences.com/event/m2d2-impact-accelerator-pitch-off/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211216
DTEND;VALUE=DATE:20211218
DTSTAMP:20260407T233621
CREATED:20211123T215852Z
LAST-MODIFIED:20211123T215852Z
UID:15008-1639612800-1639785599@www.masslifesciences.com
SUMMARY:2021 BioMAN Summit on "Technologies to Expand the Reach of Cell and Gene Therapies"
DESCRIPTION:Join Us!!\nFeaturing Keynote presentations from Professor Bruce Levine of the University of Pennsylvania and Dr. Peter Marks of USFDA. \nThe first FDA-approved cell and gene therapies revolutionized healthcare by bringing novel medicines to patient populations who lacked other treatment options. Progress is needed on multiple fronts to extend the application of these innovative product modalities to new patient populations and disease indications. \nMIT CBI’s BioMAN Consortium will host the 2021 BioMAN Summit\, which brings together thought leaders from industry\, academia\, and government for a series of invited presentations that will:\n– Identify what innovative cell and gene therapies are advancing\nthrough the development pipeline in the immuno-oncology space\nand across other disease indications.\n– Explore what the cell and gene therapy ‘factory of the future’ looks like and how it will meet the technical and logistical challenges of\nscaled-up or scaled-out manufacturing.\n– Discover what novel technologies can address current cell and gene therapy bottlenecks such as supply and variability of raw materials.\n– Examine how analytics can improve process development and manufacturing and decrease the cost of goods for these modalities.\n– Investigate strategies for introducing new technologies in the face of compressed development timelines and accelerated product\napprovals.
URL:https://www.masslifesciences.com/event/2021-bioman-summit-on-technologies-to-expand-the-reach-of-cell-and-gene-therapies/
LOCATION:A Virtual Event\, MA\, United States
ORGANIZER;CN="MIT Center for Biomedical Innovation":MAILTO:mketchum@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211215T120000
DTEND;TZID=America/New_York:20211215T130000
DTSTAMP:20260407T233621
CREATED:20211123T215942Z
LAST-MODIFIED:20211123T215942Z
UID:15012-1639569600-1639573200@www.masslifesciences.com
SUMMARY:Perspectives From the Intersection of Health Care and Technology
DESCRIPTION:Joe Corkery\, MD will discuss his personal journey along the intersection of health care and technology from his perspectives as a physician as well as a technology product leader at Google. In particular\, he will highlight key insights about health care that technology leaders need to understand\, and conversely\, key learnings for health care practitioners about the technology industry.
URL:https://www.masslifesciences.com/event/perspectives-from-the-intersection-of-health-care-and-technology/
LOCATION:Live Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211214T183000
DTEND;TZID=America/New_York:20211214T193000
DTSTAMP:20260407T233621
CREATED:20211123T220212Z
LAST-MODIFIED:20211123T220212Z
UID:14950-1639506600-1639510200@www.masslifesciences.com
SUMMARY:Koch Institute Directors Panel
DESCRIPTION:Celebrate the enduring legacy of cancer research at MIT. Current and former directors reflect on the past five decades of progress—from seminal discoveries in molecular biology and immunology to new innovations in nanotechnology and precision medicine—and look ahead to future advancements in the fight against cancer. Join in the conversation as we commemorate the people\, projects\, and promise of integrative cancer research. \nFeaturing \nPhillip Sharp\, PhD\nDirector: 1985–1991\nInstitute Professor and Professor of Biology \nRichard Hynes\, PhD\nDirector: 1991–2001\nDaniel K. Ludwig Professor for Cancer Research \nTyler Jacks\, PhD\nDirector: 2001–2021\nDavid H. Koch (1962) Professor of Biology and Daniel K. Ludwig Scholar \nMatthew Vander Heiden\, MD\, PhD\nDirector: 2021–present\nLester Wolfe (1919) Professor of Molecular Biology and Professor of Biology \nModerated by Susan Hockfield\, PhD\nMIT President Emerita and Professor of Neuroscience
URL:https://www.masslifesciences.com/event/koch-institute-directors-panel/
LOCATION:Virtual
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211213
DTEND;VALUE=DATE:20211216
DTSTAMP:20260407T233621
CREATED:20211123T215842Z
LAST-MODIFIED:20211123T215842Z
UID:15011-1639353600-1639612799@www.masslifesciences.com
SUMMARY:MIT-UCL Vaccines Bioprocess Development and Commercialization Workshop
DESCRIPTION:Massachusetts Institute of Technology\, in collaboration with University College London\, is announcing its 2021 Vaccines BioProcess Development & Commercialization Workshop.\nThis three-day workshop will explore the critical issues at the various stages of vaccine development. International experts with over 10 years’ experience in their field will lead delegates in developing their understanding in the research\, development\, operational and regulatory challenges of the vaccine market. In addition to expert lectures and excellent networking opportunities with your peers\, one case study will be conducted during the workshop about manufacturing at-risk with real examples from the influenza manufacturing process. \nThis workshop is suitable for:\n• Scientists and engineers new to the vaccines sector (recent graduates/ research scientists).\n• Scientists and technical managers who wish to broaden their knowledge in various vaccine technologies and platforms\, exploring the interplay between process choices and regulation.\n• Project Managers\, funders and policy-makers wanting to gain an understanding of vaccines. \nConfirmed Speakers Include:\nAlison Armstrong\, Merck Group\nDan Barouch\, Harvard\nBarry Buckland\, UCL\nTania Pereira Chilima\, Univercells\nKimberly Duffy\, Merck\nMark Feinberg\, IAVI\nStefanie Frank\, UCL\nAdrian Hill\, Oxford\nSteve Kolodziej\, Pfizer\nJ. Christopher Love\, MIT\nPeter Marks\, FDA\nMartina Micheletti\, UCL\nDerek O’Hagan\, GSK\nJulia O’Neill\, Moderna\nDon Parsons\, Moderna\nDavid Robinson\, B&MGF\nStacy Springs\, MIT\nDave Sullivan\, Pfizer
URL:https://www.masslifesciences.com/event/mit-ucl-vaccines-bioprocess-development-and-commercialization-workshop/
LOCATION:A Virtual Event\, MA\, United States
ORGANIZER;CN="MIT Center for Biomedical Innovation":MAILTO:mketchum@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211206T090000
DTEND;TZID=America/New_York:20211209T113000
DTSTAMP:20260407T233621
CREATED:20210802T154743Z
LAST-MODIFIED:20210802T154743Z
UID:14362-1638781200-1639049400@www.masslifesciences.com
SUMMARY:Science of Biotech 101 (December 2021)
DESCRIPTION:Member Rate applies for MassBio Member Company\, Other State Bioscience Association Member Company\, MassCONNECT Company\, or Unemployed Individual\nDescription \nScience of Biotech 101 is designed for the non-scientist. The class acts as a survey of the basic biological processes that are foundational to the biopharma and life sciences industry. Participants will apply their new understanding of basic cell and molecular biology to the work of life sciences companies that research and develop therapies and products to improve lives\, enhance agriculture\, and decrease the dependence on fossil fuels. \nSchedule\nMonday\, December 6th\, 2021 9:00-11:30 AM EST\nWednesday\, December 8th\, 2021 9:00-11:30 AM EST\nThursday\, December 9th\, 2021 9:00-11:30 AM EST \nAgenda\nSession 1: Introductions Industry Overview The Raw Materials of Biotechnology: Protein and Cells Industry Applications: The Raw Materials of Biotechnology: DNA \nSession 2: Molecular Biology: From DNA to Protein Genetics: Chromosomes\, Genes and Genomes Industry Applications \nSession 3: Genetic Engineering The Immune System Industry Applications: Mitigating Disease
URL:https://www.masslifesciences.com/event/science-of-biotech-101-december-2021/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211122T080000
DTEND;TZID=America/New_York:20211130T235900
DTSTAMP:20260407T233621
CREATED:20211123T215913Z
LAST-MODIFIED:20211123T215913Z
UID:14990-1637568000-1638316740@www.masslifesciences.com
SUMMARY:Applications open for M2D2 IMPACT Accelerator Cycle 2
DESCRIPTION:IMPACT – Innovative Medical Products – Action\, Commercialization\, Technology \nIMPACT supports bringing your Medical Device or Biotech Innovation to market. Each cycle is aligned with sponsor Areas of Interest and mentor driven to help move forward your milestones. \nApply before midnight on Tuesday 30th November for the chance to work directly with BARDA and M2D2’s exclusive resources for startups. \nhttps://my.reviewr.com/s1/site/M2D2_IMPACT \nFunded by the EDA\, there’s no cost or equity taken! \nCycle 2 commences on January 19th 2022\, check out the website for more information. \nhttps://m2d2impact.com \n#M2D2IMPACT
URL:https://www.masslifesciences.com/event/applications-open-for-m2d2-impact-accelerator-cycle-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211118T120000
DTEND;TZID=America/New_York:20211118T124500
DTSTAMP:20260407T233621
CREATED:20211022T132325Z
LAST-MODIFIED:20211022T132510Z
UID:14801-1637236800-1637239500@www.masslifesciences.com
SUMMARY:Technology as a Change Agent in Health Care
DESCRIPTION:In this Harvard Medical School Executive Education webinar\, Vivian Lee\, PhD\, will discuss lessons from her book\, The Long Fix: Solving America’s Health Care Crisis with Strategies that Work for Everyone\, and from her experiences as a former CEO and dean at University of Utah Health and now President of Verily Health Platforms (Alphabet). She’ll discuss lessons about leading change with respect to three main key constituents in health care—patients\, clinicians and payers (employers)—and explore the role of data and technology in that change.
URL:https://www.masslifesciences.com/event/technology-as-a-change-agent-in-health-care/
LOCATION:Live Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211117T160000
DTEND;TZID=America/New_York:20211117T190000
DTSTAMP:20260407T233621
CREATED:20211104T125156Z
LAST-MODIFIED:20211104T125156Z
UID:14873-1637164800-1637175600@www.masslifesciences.com
SUMMARY:The Business Side of a Biotech Startup
DESCRIPTION:Brent will share insights from his role as the Chief Business Officer and US General Manager of OncoOne\, the world’s experts in developing therapies targeting the macrophage migration inhibitory factor\, or MIF\, for patients with solid tumors and severe inflammatory conditions. \nBrent Meadows has over 25 years of US and Global commercial strategy\, launch marketing\, and business development experience from both large and small biotechnology companies including Johnson & Johnson\, Bristol-Myers Squibb\, Regeneron\, and Biogen. He joined OncoOne this fall as their Chief Business Officer and US General Manager responsible for OncoOne’s partnerships\, collaborations\, and business development efforts. He was the first commercial hire in 2007 for AVEO Oncology where he served as co-program executive for FOTIVDA® (tivozanib) helping to create the scientific narrative and expert engagement which led to the $1.4 billion collaboration with Astellas and the EMEA approval. Mr. Meadows holds an MBA from the Babson F.W. Olin Graduate School of Business and a Bachelors of Business Administration from the University of Richmond. \n_________________________________________________________________________________________ \nOpen networking will follow the presentation for those interested. Participants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/the-business-side-of-a-biotech-startup/
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T180000
DTEND;TZID=America/New_York:20211116T190000
DTSTAMP:20260407T233621
CREATED:20211022T132356Z
LAST-MODIFIED:20211022T132356Z
UID:14764-1637085600-1637089200@www.masslifesciences.com
SUMMARY:Life Science Playground: Best Practices for IP Roadblocks
DESCRIPTION:IP issues are among the most challenging and complex considerations that life science and biotech start-ups may face. Recent years have demonstrated record patent filings\, assertions of intellectual property rights\, and licensing deals created during this exciting and innovative time for the life sciences industry. \nWe aim to explore the costs\, benefit\, and role patents and IP may play in biotech start-up development. And\, in addition\, we will provide guidance on building an IP strategy that supports long-term business objectives and growth. \nCome to our playground with other entrepreneurs and thought leaders in life sciences and hear some best practices around IP roadblocks faced by pharmaceutical and biotech entities.
URL:https://www.masslifesciences.com/event/life-science-playground-best-practices-for-ip-roadblocks/
LOCATION:Online\, online
ORGANIZER;CN="Caldwell Intellectual Property Law":MAILTO:eyob@caldwellip.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T160000
DTEND;TZID=America/New_York:20211116T183000
DTSTAMP:20260407T233621
CREATED:20211022T181953Z
LAST-MODIFIED:20211022T181953Z
UID:14816-1637078400-1637087400@www.masslifesciences.com
SUMMARY:Barracuda Bowl Pitch Event
DESCRIPTION:Join us for our annual “Shark Tank”-style pitch event!\nAn impressive lineup of innovative medtech entrepreneurs will face tough questions from a panel of investors regarding their technologies\, current stage of development\, and financial projections.\nThis event is a great opportunity to connect with healthcare entrepreneurs and industry-leading investors from the Boston area.\nVIRTUAL EVENT – Presented via WebEx\nReview the Barracuda Bowl Agenda:\nOpening Remarks/Introductions\nBARDA Ventures presentation\nFireside Chat\nCompany Pitches w/ Q&A\nClosing Remarks\nVirtual Networking
URL:https://www.masslifesciences.com/event/barracuda-bowl-pitch-event-2/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T160000
DTEND;TZID=America/New_York:20211116T183000
DTSTAMP:20260407T233621
CREATED:20211004T125628Z
LAST-MODIFIED:20211004T125628Z
UID:14632-1637078400-1637087400@www.masslifesciences.com
SUMMARY:Barracuda Bowl Pitch Event
DESCRIPTION:Join us for our annual “Shark Tank”-style pitch event!\nAn impressive lineup of innovative medtech entrepreneurs will face tough questions from a panel of investors regarding their technologies\, current stage of development\, and financial projections.\nThis event is a great opportunity to connect with healthcare entrepreneurs and industry-leading investors from the Boston area.
URL:https://www.masslifesciences.com/event/barracuda-bowl-pitch-event/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211116
DTEND;VALUE=DATE:20211119
DTSTAMP:20260407T233621
CREATED:20211022T132203Z
LAST-MODIFIED:20211022T132203Z
UID:14783-1637020800-1637279999@www.masslifesciences.com
SUMMARY:Redefining Early Stage Investments (RESI)
DESCRIPTION:The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain\, connecting start-ups with 10 categories of global investors across the silos of drugs\, devices\, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups\, those seeking grants\, seed and angel capital\, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
URL:https://www.masslifesciences.com/event/redefining-early-stage-investments-resi/
END:VEVENT
END:VCALENDAR